Safety and efficacy of a docetaxel-5FU-oxaliplatin regimen with or without trastuzumab in neoadjuvant treatment of localized gastric or gastroesophageal junction cancer: A retrospective study

BACKGROUND: Triplet chemotherapy, with docetaxel-5FU-oxaliplatin FLOT regimen recently became the standard perioperative treatment for localized gastric cancer (GC). An adapted regimen called TeFOX was recently tested in metastatic setting and gave promising results. AIM: To determine safety and eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Basso, Valeria, Orry, David, Fraisse, Jean, Vincent, Julie, Hennequin, Audrey, Bengrine, Leila, Ghiringhelli, Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700033/
https://www.ncbi.nlm.nih.gov/pubmed/31435464
http://dx.doi.org/10.4251/wjgo.v11.i8.634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700033/
https://www.ncbi.nlm.nih.gov/pubmed/31435464
http://dx.doi.org/10.4251/wjgo.v11.i8.634

Ejemplares similares